Chrome Extension
WeChat Mini Program
Use on ChatGLM

Incidence of Osteonecrosis of the Jaw (ONJ) in the Randomized Non-Inferiority Phase III Trial SAKK 96/12 REDUSE Comparing Denosumab (DN) Administered Every 4 Weeks (q4w) Versus Every 12 Weeks (Q12w).

Journal of Clinical Oncology(2024)

Cited 0|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined